Search Site
Menu

In hopes of finding more and better solutions for tackling aggressive pleural mesothelioma, Baylor University’s School of Medicine has announced the beginning of a new mesothelioma clinical trial that will test the efficacy of an investigational drug in the treatment of the disease for those whose cancer has progressed after initial chemotherapy.